Vaccine industry leaders are blaming Health Secretary Robert F. Kennedy Jr. for falling sales, stock declines, and stalled investment in new vaccines. Executives say increased scrutiny of vaccine safety has disrupted long-standing approval and rollout expectations.
Posts tagged as “Sanofi”
by Brenda Baletti, Ph.D. A “substantial proportion” of infants immunized against the RSV virus with the monoclonal antibody shot nirsevimab — marketed by Sanofi and AstraZeneca as Beyfortus — developed…
By daniel_g A U.S. Food & Drug Administration (FDA) panel recently recommended approval for AstraZeneca’s new monoclonal antibody, which supposedly protects infants and toddlers up to…